Search research articles
Contact Us
Filters
Showing results (181-190 of 266) with videos related to
Page
of 27
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 7, 2001
Immediate allograft dysfunction due to atheroembolic disease
P R Chaudhury, J W Alexander, M R First, et al.
Transplantation Proceedings
|
February 1, 1991
The use of OKT3 in the treatment of acute vascular rejection
T J Schroeder, M A Weiss, R D Smith, et al.
Transplantation Proceedings
|
February 1, 1987
The effect of oral metoclopramide on the absorption of cyclosporine
N K Wadhwa, T J Schroeder, E O'Flaherty, et al.
Transplantation
|
December 10, 1997
Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection
S Kamath, D Dean, V R Peddi, et al.
Clinical Transplantation
|
February 1, 1996
Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation subpopulations
M R First, T J Schroeder, A P Monaco, et al.
Therapeutic Drug Monitoring
|
December 1, 1987
Cyclosporine drug interactions: a review
N K Wadhwa, T J Schroeder, A J Pesce, et al.
Transplantation Proceedings
|
March 27, 2001
Quality of life as a predictor of morbidity, mortality, and resource utilization after solid organ transplant
A L Phillips, E L Walker, J E Martin, et al.
Transplantation Proceedings
|
June 24, 1998
Primary therapy with OKT3 for biopsy-proven acute renal allograft rejection
S Kamath, D Dean, V R Peddi, et al.
Transplantation Proceedings
|
December 29, 1998
A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus
A J Daoud, T J Schroeder, M Shah, et al.
Transplantation Proceedings
|
March 27, 2001
Quality of life as a predictor of morbidity, mortality, and resource utilization after solid-organ transplant
A L Phillips, E L Walker, J E Martin, et al.
Page
of 27
Search research articles
Search
Showing results (181-190 of 266) with videos related to
Sort By:
Page
of 27
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 7, 2001
Immediate allograft dysfunction due to atheroembolic disease
P R Chaudhury, J W Alexander, M R First, et al.
Transplantation Proceedings
|
February 1, 1991
The use of OKT3 in the treatment of acute vascular rejection
T J Schroeder, M A Weiss, R D Smith, et al.
Transplantation Proceedings
|
February 1, 1987
The effect of oral metoclopramide on the absorption of cyclosporine
N K Wadhwa, T J Schroeder, E O'Flaherty, et al.
Transplantation
|
December 10, 1997
Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection
S Kamath, D Dean, V R Peddi, et al.
Clinical Transplantation
|
February 1, 1996
Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation subpopulations
M R First, T J Schroeder, A P Monaco, et al.
Therapeutic Drug Monitoring
|
December 1, 1987
Cyclosporine drug interactions: a review
N K Wadhwa, T J Schroeder, A J Pesce, et al.
Transplantation Proceedings
|
March 27, 2001
Quality of life as a predictor of morbidity, mortality, and resource utilization after solid organ transplant
A L Phillips, E L Walker, J E Martin, et al.
Transplantation Proceedings
|
June 24, 1998
Primary therapy with OKT3 for biopsy-proven acute renal allograft rejection
S Kamath, D Dean, V R Peddi, et al.
Transplantation Proceedings
|
December 29, 1998
A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus
A J Daoud, T J Schroeder, M Shah, et al.
Transplantation Proceedings
|
March 27, 2001
Quality of life as a predictor of morbidity, mortality, and resource utilization after solid-organ transplant
A L Phillips, E L Walker, J E Martin, et al.
Page
of 27